SenesTech (SNES) Stock Price, News & Analysis

Company Overview

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Key Stats

• Today's Range: $2.94 to $3.45
• 50-Day Range: $2.76 to $3.69
• 52-Week Range: $1.90 to $10.90
• Volume: 81,665 shs
• Average Volume: 93,113 shs
• Market Capitalization: $3.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Buy

SenesTech Stock Analysis - MarketRank™

SenesTech scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

SenesTech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

SenesTech has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for SenesTech are expected to grow in the coming year, from ($10.22) to ($6.24) per share.

Price to Book Value per Share Ratio

SenesTech has a P/B Ratio of 0.25. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.92% of the float of SenesTech has been sold short.

Short Interest Ratio / Days to Cover

SenesTech has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SenesTech has recently decreased by 18.50%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SenesTech does not currently pay a dividend.

Dividend Growth

SenesTech does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.92% of the float of SenesTech has been sold short.

Short Interest Ratio / Days to Cover

SenesTech has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SenesTech has recently decreased by 18.50%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.7 / 5
• News Sentiment: 0.05

News Sentiment

SenesTech has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for SenesTech this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SenesTech insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 9.99% of the stock of SenesTech is held by insiders.

Percentage Held by Institutions

Only 5.19% of the stock of SenesTech is held by institutions.

SNES Stock Analysis - Frequently Asked Questions

How have SNES shares performed this year?

SenesTech's stock was trading at $3.31 at the beginning of 2025. Since then, SNES shares have decreased by 8.5% and is now trading at $3.03.
View the best growth stocks for 2025 here.

How were SenesTech's earnings last quarter?

SenesTech, Inc. (NASDAQ:SNES) released its quarterly earnings results on Thursday, August, 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.20) by $0.12. The firm earned $0.46 million during the quarter, compared to analysts' expectations of $0.49 million. SenesTech had a negative net margin of 403.51% and a negative trailing twelve-month return on equity of 150.33%.

When did SenesTech's stock split?

Shares of SenesTech reverse split on Thursday, July 25th 2024. The 1-10 reverse split was announced on Tuesday, July 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did SenesTech IPO?

SenesTech (SNES) raised $15 million in an initial public offering (IPO) on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

How do I buy shares of SenesTech?

Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SenesTech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SenesTech investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CymaBay Therapeutics (CBAY), General Electric (GE), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

• Last Earnings: 8/08/2024
• Today: 2/21/2025
• Next Earnings (Estimated): 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Agricultural chemicals
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:SNES
• CUSIP: N/A
• CIK: 1680378
• Web: www.senestech.com
• Phone: (928) 779-4143
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $10.00
• High Stock Price Target: $10.00
• Low Stock Price Target: $10.00
• Potential Upside/Downside: +230.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,710,000.00
• Net Margins: -403.51%
• Pretax Margin: -403.51%
• Return on Equity: -150.33%
• Return on Assets: -125.40%

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 6.32
• Quick Ratio: 4.92

Sales & Book Value

• Annual Sales: $1.19 million
• Price / Sales: 2.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $12.36 per share
• Price / Book: 0.25

Miscellaneous

• Outstanding Shares: 1,030,000
• Free Float: 931,000
• Market Cap: $3.12 million
• Optionable: Not Optionable
• Beta: 0.36